calixformofpowerofattorn

0001406666-21-000106.txt : 20211004 0001406666-21-000106.hdr.sgml : 20211004 20211004181817 ACCESSION NUMBER: 0001406666-21-000106 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20210925 FILED AS OF DATE: 20211004 DATE AS OF CHANGE: 20211004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eleniak Shane Todd Marshall CENTRAL INDEX KEY: 0001886143 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34674 FILM NUMBER: 211304402 MAIL ADDRESS: STREET 1: C/O CALIX, INC. STREET 2: 2777 ORCHARD PARKWAY CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CALIX, INC CENTRAL INDEX KEY: 0001406666 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATION SERVICES, NEC [4899] IRS NUMBER: 680438710 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2777 ORCHARD PARKWAY CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 408-514-3000 MAIL ADDRESS: STREET 1: 2777 ORCHARD PARKWAY CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: CALIX NETWORKS INC DATE OF NAME CHANGE: 20070713 3 1 wf-form3_163338587987674.xml FORM 3 X0206 3 2021-09-25 0 0001406666 CALIX, INC (CALX) 0001886143 Eleniak Shane Todd Marshall C/O CALIX, INC. 2777 ORCHARD PARKWAY SAN JOSE CA 95134 0 1 0 0 EVP, Products Stock Option (right to buy) 6.95 2027-10-01 Common Stock 90000.0 D Stock Option (right to buy) 5.95 2027-12-29 Common Stock 126000.0 D Stock Option (right to buy) 7.0 2028-08-01 Common Stock 50000.0 D Stock Option (right to buy) 8.03 2029-02-14 Common Stock 48000.0 D Stock Option (right to buy) 9.16 2030-01-31 Common Stock 200000.0 D Stock Option (right to buy) 9.16 2030-01-31 Common Stock 50000.0 D 100% of the shares subject to the option grant are fully vested and exercisable. 100% of the shares subject to the option grant are fully vested and exercisable. On August 1, 2018, the reporting person was awarded a nonqualified stock option grant covering 50,000 shares of common stock. 25% of the shares subject to the stock option grant vested on August 1, 2019, with the remainder having vested quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of September 25, 2021, 37,500 shares subject to the option grant are fully vested and exercisable. On February 14, 2019, the reporting person was awarded a performance-based nonqualified stock option grant covering 160,000 shares of common stock. On February 13, 2020, the Compensation Committee of Calix, Inc. determined that the performance criteria governing 30% of the grant had been achieved. Each nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on February 13, 2020; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from February 13, 2020. As of September 25, 2021, 30,000 shares subject to the option grant are fully vested and exercisable. On January 31, 2020, the reporting person was awarded a performance-based nonqualified stock option grant covering 200,000 shares of common stock. On February 13, 2021, the Compensation Committee of Calix, Inc. determined that the performance criteria governing the grant had been achieved. Each nonqualified stock option award shall vest: (i) as to 25% of the shares of common stock subject to the stock option award, on January 31, 2021; and (ii) as to the remaining 75% of the shares of common stock subject to the stock option award, quarterly in equal installments over 36 months from January 31, 2021. As of September 25, 2021, 75,000 shares subject to the option grant are fully vested and exercisable. 25% of the shares subject to the stock option grant vested on January 31, 2021, with the remainder vesting quarterly thereafter in substantially equal installments over the next 36 months, subject to the reporting person's service through each applicable vesting date. As of September 25, 2021, 18,750 shares subject to the option grant are fully vested and exercisable. /s/ Tom Gemetti as Attorney-in-fact for Shane Eleniak 2021-10-04 EX-24 2 calixformofpowerofattorn.htm POA - ELENIAK - 20210927 calixformofpowerofattorn

POWER OF ATTORNEY I appoint each of Cory Sindelar, Suzanne Tom, Tom Gemetti, John Cunningham and Patricia Knox, signing singly and in their capacity as an employee of Calix, Inc. (“Calix”), with full power of substitution, as my attorney-in-fact to: (1) prepare, execute in my name and on my behalf, and submit to the U.S. Securities and Exchange Commission (“SEC”) a Form ID, including amendments, and any other documents necessary or appropriate to obtain codes and passwords enabling me to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934 or any rule or regulation of the SEC; (2) execute for and on behalf of me, in my capacity as an officer of Calix, Forms 3, 4, and 5 and any amendments in accordance with Section 16(a) of the Securities Exchange Act of 1934 and its rules; (3) do and perform any acts for and on behalf of me which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, or amendments, and timely file such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the above which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, me, it being understood that the documents executed by such attorney-in-fact on behalf of me under this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion. I grant to each such attorney-in-fact full power and authority to perform any act necessary or proper to be done in the exercise of any of the rights and powers granted, as fully as I might do if personally present, with full power of substitution or revocation, ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers granted. I acknowledge that the above attorneys-in-fact, in serving in such capacity at my request, are not assuming, nor is Calix assuming, any of my responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This Power of Attorney revokes all earlier powers of attorney signed by me and shall remain in effect until I am no longer required to file Forms 3, 4, and 5 with respect to my holdings of and transactions in securities issued by Calix, unless earlier revoked by me in a signed writing delivered to the above attorneys-in-fact. Signature: Print Name: Shane Eleniak Effective Date: 9/27/2021